Clinical Trials Browser

INDUSTRY × Colorectal Cancer Metastatic × Panitumumab × Clear all

NCT04169347 2023-07-27

FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colorectal Cancer Metastatic